FSA Assumes All Collar Products Have Been Mis-Sold

June 29 (Bloomberg) -- Financial Services Authority Managing Director Martin Wheatley talks about mis-sold interest-rate derivatives to small and medium-sized businesses. He spoke with Bloomberg's Lindsay Fortado in London. (Source: Bloomberg)

Will Acquiring Allergan Impact Pfizer's R&D?
43:49 - Dr. Beth Seidenberg, Kleiner Perkins Caufield & Byers general partner, discusses the financial implications of the Pfizer-Allergan deal. She speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • How to Manage the Hype in Tech Startups
  • Yuan Addition to SDR to Draw Inflows to China: Pihlman
  • U.S. Markets: What Caused Today's Weakness?